Cytomegalovirus infection following stem cell transplantation

MeSH terms

• Acyclovir / administration & dosage
• Acyclovir / therapeutic use
• Antibodies, Viral / blood
• Antiviral Agents / administration & dosage
• Antiviral Agents / therapeutic use
• Blood Donors
• Cidofovir
• Cytomegalovirus / immunology
• Cytomegalovirus / isolation & purification
• Cytomegalovirus / physiology
• Cytomegalovirus Infections / diagnosis
• Cytomegalovirus Infections / etiology
• Cytomegalovirus Infections / prevention & control
• Cytomegalovirus Infections / therapy
• Cytomegalovirus Infections / transmission
• Cytosine / administration & dosage
• Cytosine / analogs & derivatives
• Cytosine / therapeutic use
• Foscarnet / administration & dosage
• Foscarnet / therapeutic use
• Ganciclovir / administration & dosage
• Ganciclovir / therapeutic use
• Hematopoietic Stem Cell Transplantation / adverse effects*
• Hematopoietic Stem Cells / virology
• Humans
• Immunocompromised Host
• Immunotherapy, Adoptive
• Leukocyte Transfusion
• Organophosphonates*
• Organophosphorus Compounds / administration & dosage
• Organophosphorus Compounds / therapeutic use
• Premedication
• Risk Factors
• Tissue Donors
• Transfusion Reaction
• Virus Latency